These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27081421)

  • 1. An Insight Into the Immunologic Events and Risk Assessment in Renal Transplantation.
    Khan A; Nasr P; El-Charabaty E; El-Sayegh S
    J Clin Med Res; 2016 May; 8(5):367-72. PubMed ID: 27081421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry.
    Narula J; Bennett LE; DiSalvo T; Hosenpud JD; Semigran MJ; Dec GW
    Transplantation; 1997 Mar; 63(6):861-7. PubMed ID: 9089227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New scoring system identifies kidney outcome with radiation therapy in acute renal allograft rejection.
    Chen LM; Godinez J; Thisted RA; Woodle ES; Thistlewaite JR; Powers C; Haraf D
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):999-1003. PubMed ID: 10705023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basiliximab: a review of its use as induction therapy in renal transplantation.
    Chapman TM; Keating GM
    Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies.
    Eikmans M; Gielis EM; Ledeganck KJ; Yang J; Abramowicz D; Claas FFJ
    Front Med (Lausanne); 2018; 5():358. PubMed ID: 30671435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for and management of post-transplantation cardiovascular disease.
    Fellström B
    BioDrugs; 2001; 15(4):261-78. PubMed ID: 11437691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal infections in renal transplant patients.
    Khan A; El-Charabaty E; El-Sayegh S
    J Clin Med Res; 2015 Jun; 7(6):371-8. PubMed ID: 25883698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
    Staatz CE; Tett SE
    Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression in elderly renal transplant recipients: are current regimens too aggressive?
    Meier-Kriesche HU; Kaplan B
    Drugs Aging; 2001; 18(10):751-9. PubMed ID: 11735622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus in transplant rejection.
    Rath T
    Expert Opin Pharmacother; 2013 Jan; 14(1):115-22. PubMed ID: 23228138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
    Hurkmans DP; Verhoeven JGHP; de Leur K; Boer K; Joosse A; Baan CC; von der Thüsen JH; van Schaik RHN; Mathijssen RHJ; van der Veldt AAM; Hesselink DA
    J Immunother Cancer; 2019 Jul; 7(1):182. PubMed ID: 31300068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients.
    Lim WH; Chadban SJ; Campbell S; Dent H; Russ GR; McDonald SP
    Nephrology (Carlton); 2010 Apr; 15(3):368-76. PubMed ID: 20470309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient.
    Kutzler HL; Ye X; Rochon C; Martin ST
    Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.